Calendar Opportunities Companies Compare Analytics Learn Watchlist

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Loading market movers...

Free biotech catalyst calendar with AI-powered predictions. Track FDA decisions, PDUFA dates, clinical trial results, and Phase 3 readouts. Real-time alerts for biotech investors.

Quick Links

This Week's Catalysts
Full Calendar
Catalyst Types
Search Companies
Biotech Glossary
Embed Widget

Legal

About
ML Track Record
Privacy
Terms

Data Sources

ClinicalTrials.gov
SEC EDGAR
FDA

⚠️ Not Financial Advice (NFA)

CatalystAlert provides data aggregation and analysis tools only. All probability scores and predictions are based on historical data and are NOT guarantees of future results. Past performance does not indicate future success. We are not responsible for the accuracy of third-party data sources. Always consult a qualified financial advisor before making investment decisions.

Data may be delayed or incomplete. Use at your own risk.

Monte Rosa Therapeutics, Inc.

GLUE

$1.11B

Small Cap

NASDAQBiotechnology🇺🇸North America147 employees

Drugs in Pipeline

Phase 3 Programs

Upcoming Catalysts

Next Catalyst

May 15, 2026

21w

Drug Pipeline

Drug Name	Phase	Indication	Designations
Oral MRT-2359	Phase 2	NSCLC	-

Catalyst Timeline

1 upcoming, 0 past

Phase 2Next

Oral MRT-2359 Phase 2 Results Expected

May 2026~Oral MRT-2359

Primary completion for Oral MRT-2359 trial (NCT05546268) in NSCLC

Source

Regulatory Approvals

GLUE News